The prevalence of diabetes is high and increases rapidly. In 2007, 740,000 patients were diagnosed with diabetes in The Netherlands, 90% of these patients with type 2 diabetes [1]. On the long-term, elevated blood glucose levels in type 2 diabetes patients can cause both macrovascular complications such as cardiovascular disease and stroke, and microvascular complications such as renal disease, blindness, foot ulcerations and nerve damage [1], [2]. An important goal in the treatment of type 2 diabetes is to achieve good glycaemic control (lowering the blood glucose to a level close to normal), thereby reducing the incidence of these complications. One of the key strategies in achieving glycaemic control is long-term adherence to oral antidiabetics [3], [4], [5]. However, many patients experience difficulties in following the treatment as agreed with the health care provider. Reported adherence to oral antidiabetics ranges from 36% to 93% [6]. Although patients’ reasons for not following the prescribed treatment are diverse, one of the most commonly reported barriers to adherence in type 2 diabetes patients is forgetfulness [7], [8]. Reminding patients of their medication intake can help them overcome this barrier [9], [10]. Studies investigating the effect of reminder packaging (incorporating a date and time for medication to be taken in the package) and audiovisual reminders on medication devices revealed improved adherence rates, but the effects were only modest [11], [12], [13]. Nowadays, as the number of mobile phone connections exceeds five billion worldwide [14], reminding patients of their medication intake through Short Message Service (SMS) is increasingly being implemented in interventions aimed at improving adherence. SMS allows for instantaneous delivery of short text messages to individuals at any time, place and setting. As such, SMS-reminding is a relatively simple method with low intrusiveness and relatively low costs [9]. Previous studies evaluating the effect of SMS reminders on adherence showed positive results. Improved adherence rates to e.g. inhaler treatment in asthma patients [15], antiretroviral therapy in HIV patients [16], [17], [18], and immunosuppressive medication in liver transplant recipients [19] were demonstrated. In these previous studies, SMS reminders were sent regardless whether or not the medication was taken. This method may cause annoyance and may eventually lead to loss of effectiveness when the automated reminders become a routine. Pop-Eleches et al. found that daily reminders, as opposed to weekly reminders, did not improve adherence to antiretroviral therapy. They considered habituation to a frequent stimulus or intrusiveness of daily messages as possible explanations [18].
In our study, Real Time Medication Monitoring (RTMM) was introduced to avoid sending reminders to patients who already took their medication. RTMM combines electronic monitoring with SMS reminders. Like other electronic monitoring devices such as the Medication Event Monitoring System (MEMS®), RTMM uses an electronic medication dispenser that records each date and time of dispenser opening at a central server, providing accurate and detailed data on actual medication use. However, RTMM registers these data in real time, making it possible to identify a missed dose as it happens. Because of the real time registration of patients’ medication use, the RTMM system has the unique feature to remind patients only if they forget to take their pills, thus to intervene only when this is necessary. In practice, this means that when a dispenser opening is registered, no SMS reminder is sent, but when the dispenser is not opened in time, the patient receives a SMS as a reminder to take the medication. As such, habituation or a high intrusiveness can be avoided.
Two pilot studies involving HIV patients on antiretroviral therapy in Uganda used real time monitoring with Wisepill [20] and the Med-eMonitor [21]. However, the real time monitoring was not combined with an intervention (such as reminding) when patients miss a dose. Both studies did show that these devices were feasible to use and accepted by patients.
Our study is, to our knowledge, the first to evaluate this new Real Time Medication Monitoring system with customized SMS-reminding. Furthermore, up to now, no study has investigated the use of SMS reminders to support type 2 diabetes patients in their medication use. Therefore, the main aim of this study is to evaluate the effect of SMS reminders on the adherence to oral medication in type 2 diabetes patients. The use of an electronic monitoring device can already contribute to a higher adherence because of patients’ awareness of being monitored [22]. To eliminate this effect, all patients in this study were electronically monitored with RTMM.
Patients’ experiences with receiving SMS reminders are important aspects when it comes to patients’ acceptance of the system and its integration in everyday life. For example, patients who perceive the reminders as disturbing are less likely to use RTMM in daily life than patients who perceive the reminders as a support in their medication use. The second aim of this study is thus to assess patients’ experiences.